Related content

A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: ovarian response and clinical outcomes

By Kilani Z.  

Human Reproduction, Vol. 18, Iss. 6, 2003-06 ,pp. : 1194-1199

Oxford University Press

Access to resources Recommend Favorite

IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression

By Bjercke S.   Fedorcsak P.   Åbyholm T.   Storeng R.   Ertzeid G.   Oldereid N.   Omland A.   Tanbo T.  

Human Reproduction, Vol. 20, Iss. 9, 2005-09 ,pp. : 2441-2447

Oxford University Press

Access to resources Recommend Favorite

Cetrorelix in an oral contraceptive-pretreated stimulation cycle compared with buserelin in IVF/ICSI patients treated with r-hFSH: a randomized, multicentre, phase IIIb study

By Huirne J.A.   Hugues J.N.   Pirard C.   Fischl F.   Sage J.C.   Pouly J.L.   Obruca A.   Braat D.M.   van Loenen A.C.D.   Lambalk C.B.  

Human Reproduction, Vol. 21, Iss. 6, 2006-06 ,pp. : 1408-1415

Oxford University Press

Access to resources Recommend Favorite

A prospective study of predictive factors of ovarian response in ‘standard’ IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram

By Popovic‐Todorovic B.  

Human Reproduction, Vol. 18, Iss. 4, 2003-04 ,pp. : 781-787

Oxford University Press

Access to resources Recommend Favorite

A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a ‘standard’ dose of 150 IU/day in ‘standard’ patients undergoing IVF/ICSI treatment

By Popovic‐Todorovic B.  

Human Reproduction, Vol. 18, Iss. 11, 2003-11 ,pp. : 2275-2282

Oxford University Press

Access to resources Recommend Favorite